Plasma enteroglucagon levels in different models of intestinal resection in the rat. 1994

I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
Experimental Surgery Service, Hospital La Paz, Madrid, Spain.

To assess the influence of the different intestinal segments on the plasma enteroglucagon level, three models of intestinal resection in the rat were studied (jejunal, ileal, 90%). The basal values for this peptide and those obtained after an infusion of intraduodenal glucose were compared. The results obtained in basal/post-glucose infusion were: 50% proximal (jejunum): 220/728 pg/ml; 50% distal (ileum): 10/233 pg/ml; and the middle 90%: 108/297 pg/ml. The glucose infusion produced a maximal response, permitting a better evaluation of the differences among the three resection models. The highest levels corresponded to the group in which the entire ileum was conserved.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D004763 Glucagon-Like Peptides Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms. Enteroglucagon,Enteroglucagons,Glucagon-Like Peptide,Glucagon-Like Polypeptide,Gut Glucagon,Glucagon-Like Polypeptides,Glucagon Like Peptide,Glucagon Like Peptides,Glucagon Like Polypeptide,Glucagon Like Polypeptides,Glucagon, Gut,Peptide, Glucagon-Like,Polypeptide, Glucagon-Like
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000222 Adaptation, Physiological The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT. Adaptation, Physiologic,Adaptations, Physiologic,Adaptations, Physiological,Adaptive Plasticity,Phenotypic Plasticity,Physiological Adaptation,Physiologic Adaptation,Physiologic Adaptations,Physiological Adaptations,Plasticity, Adaptive,Plasticity, Phenotypic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
November 1981, Life sciences,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
January 1985, Gut,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
December 1972, Clinical science,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
January 1987, Gut,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
July 1983, The British journal of surgery,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
November 1984, Digestive diseases and sciences,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
January 1985, Gastroenterology,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
January 1983, Virchows Archiv. B, Cell pathology including molecular pathology,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
January 1984, Digestion,
I A Gómez de Segura, and E de Miguel, and A Mata, and R Codoceo, and H Bonet, and J A Rodríguez Montes
October 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!